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Prior studies in our laboratory have suggested that the CC chemokine macrophage inflammatory protein-1a
(MIP-1a) may be an important mediator in the blinding ocular inflammation which develops following herpes
simplex virus type 1 (HSV-1) infection of the murine cornea. To directly test this hypothesis, MIP-1a-deficient
(2/2) mice and their wild-type (1/1) counterparts were infected topically on the scarified cornea with 2.5 3
105 PFU of HSV-1 strain RE and subsequently graded for corneal opacity. Four weeks postinfection (p.i.), the
mean corneal opacity score of 2/2 mice was 1.1 6 0.3 while that of the 1/1 mice was 3.7 6 0.5. No detectable
infiltrating CD41 T cells were seen histologically at 14 or 21 days p.i. in 2/2 animals, whereas the mean CD41
T-cell count per field (36 fields counted) in 1/1 hosts was 26 6 2 (P < 0.001). In addition, neutrophil counts
in the 2/2 mouse corneas were reduced by >80% in comparison to the wild-type controls. At 2 weeks p.i., no
interleukin-2 or gamma interferon could be detected in six of seven 2/2 mice, whereas both T-cell cytokines
were readily demonstrable in 1/1 mouse corneas. Also, MIP-2 and monocyte chemoattractant protein-1
protein levels were significantly lower in MIP-1a 2/2 mouse corneas than in 1/1 host corneas, suggesting
that MIP-1a directly, or more likely indirectly, influences the expression of other chemokines. Interestingly,
despite the paucity of infiltrating cells, HSV-1 clearance from the eyes of 2/2 mice was not significantly
different from that observed in 1/1 hosts. We conclude that MIP-1a is not needed to control virus growth in
the cornea but is essential for the development of severe stromal keratitis.
Herpes simplex virus type 1 (HSV-1) infection of the murine
cornea triggers an intense inflammatory response which per-
sists and can result in blindness. This disease, called herpes
stromal keratitis (HSK), is characterized by the extensive in-
filtration of polymorphonuclear and mononuclear cells (34,
36). While immune CD41 T cells play a critical role in initiat-
ing the immunopathological response, neutrophils are the
most prominent infiltrating cell type seen in the cornea.
The events promoting leukocyte infiltration into sites of in-
fection are complex and involve the participation of various
factors, including chemokines. Chemokines are a superfamily
of more than 30 low-molecular-mass heparin-binding polypep-
tides which participate in the directed migration of leukocyte
subsets (2, 21, 33). They are divided into two main families on
the basis of structure. The alpha members have a CXC con-
struction wherein the two initial cysteines are separated by an
intervening amino acid, while the initial beta family cysteines
are adjacent (CC) to each other. Prior studies in our laboratory
have shown that HSV-1 ocular infection in BALB/c mice in-
duces message for at least seven different chemokines (30).
Administration of anti-HSV gD monoclonal antibody, which
protects against HSK (20), was associated with reduced mes-
sage for macrophage inflammatory protein-2 (MIP-2), mono-
cyte chemoattractant protein-1 (MCP-1), MIP-1a, and MIP-
1b. This finding suggested that one or more of these four
chemokines may play an essential role in HSK development.
MIP-1a has been reported to be an important chemoattractant
for T cells and neutrophils in the mouse (38, 39) and was
therefore an attractive choice for further analysis. This chemo-
kine was originally discovered as a protein secreted by the
mouse macrophage cell line RAW264.7 following exposure to
endotoxin (25, 39). The mature product is 69 amino acids and
is produced by several different cell types, including alveolar
macrophages, T cells, bronchial epithelial cells, and neutro-
phils (17, 23, 26). Like other chemokines, MIP-1a binds to a
G-protein-coupled seven-transmembrane receptor (7). It also
binds to heparin (16), an extracellular matrix glycosaminogly-
can.
Recently, mice which have a deletion in almost half of the
MIP-1a coding region as well as 300 nucleotides of DNA
upstream of the mRNA start site have been generated (5). We
have used these gene knockout mice to investigate the function
of MIP-1a in HSV-1-induced ocular inflammation. Following
HSV-1 corneal infection, HSK was strikingly diminished in
MIP-1a-deficient (2/2) hosts although virus replication and
clearance did not differ significantly from that seen in infected
wild-type (1/1) mice. These results demonstrate that the ab-
rogation of a single chemokine can dramatically affect the
outcome of virus infection in the murine eye.
MATERIALS AND METHODS
Animals. The generation of mice with a targeted disruption of the gene
encoding MIP-1a has been previously described (5). Both male and female
mutant (2/2) mice and their wild-type (1/1) counterparts were used when 6 to
10 weeks old. The animals were housed in plastic cages in a room with a 12-h
light/12-h dark cycle.
Virus infection. HSV-1 strain RE, a known HSK inducer (20), was used to
initiate infection. Virus stocks were grown and titrated on Vero cells as previ-
ously described (19). Mice were anesthetized with 1.0 mg of sodium phenobar-
bital in 0.2 ml of phosphate-buffered saline injected intraperitoneally. The right
eye was lightly scarified by three twists of a 2-mm corneal trephine. A 2-ml
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volume containing 2.5 3 105 to 7 3 105 PFU of virus was then dropped onto the
corneal surface and massaged in with the eyelids. Eyes were examined weekly
with a dissecting biomicroscope. Corneal opacity was graded on a scale of 0 to 14
as follows: 0, clear cornea; 11, slight corneal haze; 12, moderate corneal opac-
ity; 13, severe corneal opacity with iris visible; 14, severe corneal opacity with
iris not visible. Eyes were examined in a coded fashion, with the reader unaware
of the treatment given.
Measurement of neutralizing antibody. To determine whether MIP-1a influ-
ences the titers of neutralizing antibody, sera were collected at various times
after corneal infection with HSV-1 and titrated for neutralizing antibodies by the
plaque reduction method (19). Equal volumes of sera diluted as desired were
added to tubes containing 0.2 ml of an HSV-1 suspension (3 3 103 PFU/ml).
These virus-serum mixtures were incubated for 30 min at 37°C, and then 0.1-ml
aliquots were placed on a Vero cell monolayer. Controls received virus only.
After adsorption for 1 h at room temperature, the monolayers were overlaid with
4 ml of 0.5% methylcellulose solution and incubated for 2 days at 37°C in a 5%
CO2 atmosphere. The neutralizing titer was taken as the dilution of serum that
reduced the mean PFU by 50% in comparison with the controls.
Assay of ocular tissue for infectious HSV-1. To test whether the absence of
MIP-1a affected HSV-1 replication in the cornea, individual whole eyes were
excised and placed in 600 ml of 2% fetal bovine serum in Dulbecco modified
Eagle medium with antibiotics. Preparations were frozen to 270°C, thawed, and
homogenized in a Ten Broeck homogenizer (Bellco, Vineland, N.J.). The ho-
mogenates were frozen and thawed again followed by sonication for 15 s in a
Sonic 300 Dismembrator (Artek Systems Corporation, Farmingdale, N.Y.). The
supernatants were then titrated for infectious virus on Vero cell monolayers in a
standard 48-h plaque assay (19).
Histologic examination. Infected eyes were enucleated, fixed in 10% neutral
buffered formalin, and embedded in paraffin, and multiple 5-mm sections were
prepared. Sections were stained with hematoxylin-eosin, mounted in Permount,
and coverslipped for photomicroscopy.
Cytokine and chemokine quantitation. To determine the in vivo levels of
cytokine or chemokine proteins, and to test whether the absence of MIP-1a
influenced the level of these proteins, corneas were removed from MIP-1a 1/1
and 2/2 mice on various days after infection. Corneas were placed in 500 ml of
serum-free RPMI 1640 with antibiotic-antimycotic solution (GIBCO BRL).
Samples were stored at 270°C until assayed. Samples were thawed, homoge-
nized, minced, sonicated for 30 s, and clarified by centrifugation at 150 3 g for
10 min. The clarified cell lysates were assayed for interleukin-2 (IL-2), IL-4,
gamma interferon (IFN-g), MIP-1a, MIP-2, and MCP-1, using commercial en-
zyme-linked immunosorbent assay (ELISA) kits. The IL-2 kit (assay sensitivity,
3 pg/ml), IL-4 kit (assay sensitivity, 5 pg/ml), and IFN-g kit (assay sensitivity, 15
pg/ml) were purchased from Endogen, Inc. (Boston, Mass.). The MCP-1 kit
(assay sensitivity, 9 pg/ml) was purchased from Biosource International (Cama-
rillo, Calif.). The MIP-2 kit (assay sensitivity, 1.5 pg/ml) and MIP-1a kit (assay
sensitivity, 3 pg/ml) were purchased from R & D Systems (Minneapolis, Minn.).
Immunohistochemistry. Immunohistochemical examination of infected cor-
neas was performed as previously described (12). Infected eyes were enucleated
and embedded in O.C.T. (Tissue Tek, Miles, Naperville, Ill.) and snap-frozen in
an isopentane dry ice bath, and 6-mm sections were cut at 220°C. The sections
were fixed in cold acetone for 10 min and then exposed to the primary antibodies
overnight at 4°C. Rat monoclonal antibodies to CD4 T cells (clone GK1.5;
American Type Culture Collection, Rockville, Md.) and granulocytes (RB6-8C5;
a gift from R. Coffman, DNAX Research Institute, Palo Alto, Calif.) were used
as primary antibodies at 2 mg/ml. The sections were then stained by the strept-
avidin-biotin complex immunoperoxidase staining procedure (Zymed Laborato-
ries, South San Francisco, Calif.). The sections were washed for 10 min and
incubated for 30 min with biotinylated rabbit anti-rat immunoglobulin G (heavy
and light chains) which had been adsorbed with mouse serum protein and diluted
in a mouse skin extract. Following two washes, the sections were exposed to 3%
H2O2 in methanol and washed two times for 10 min each to block endogenous
peroxidase activity. The sections were then incubated for 10 min with the strept-
avidin-biotinylated peroxidase complex. Following two washes, sections were
incubated for 5 min in AEC (3-amino-9-ethylcarbazole; Sigma Chemical Com-
pany) solution, which was made from 1 ml of AEC (4 mg/ml) in N,N-dimethyl-
formamide, 14 ml of 0.1 M acetate buffer (pH 5.5), and 150 ml of 3% H2O2. The
slides were then washed in distilled water and counterstained with Mayer’s
hematoxylin for 6 min. The microscopic slides containing CD41 and neutrophil
staining were counted in a coded fashion, with the reader unaware of the
treatment given.
Statistical analysis. The Mann-Whitney U test was used to determine signif-
icant differences in the corneal opacity scores between control and test groups.
Student’s t test was used to determine significant differences in the number of
CD41 T cells and neutrophils in the corneas of MIP-1a 1/1 and 2/2 mice. The
level of confidence at which the experiments were judged significant was P ,
0.05.
RESULTS
MIP-1a expression in the HSV-1-infected cornea. The ki-
netics of MIP-1a production following HSV-1 corneal infec-
tion was determined by ELISA. Figure 1 shows that no protein
was detected in 1/1 corneas before day 5 postinfection. His-
tologically examination of the corneas at various times postin-
fection indicated that the appearance of MIP-1a coincided
with the initiation of pronounced leukocyte infiltration into the
infected cornea. This CC chemokine continued to be synthe-
sized for 21 days postinfection in all 1/1 mice examined.
However, at 4 weeks postinfection only 60% of the corneas
were positive, and in these the mean concentration had de-
creased to 6 pg/eye. No MIP-1a protein was detected in any of
the 32 mutant hosts examined.
HSK development in MIP-1a 1/1 and 2/2 mice. MIP-1a
1/1 and 2/2 mice were evaluated clinically for the develop-
ment of HSK following HSV-1 corneal infection. Figure 2
shows that 129 3 C57BL/6 hosts developed corneal opacity in
a time frame quite similar to that previously reported for
BALB/c mice (13). In sharp contrast, animals with the dis-
rupted MIP-1a gene were strikingly resistant to the develop-
ment of severe HSK. These observations were confirmed in
FIG. 1. Time course of MIP-1a chemokine protein expression in HSV-1-
infected corneas. At the indicated times after infection, four to seven eyes from
MIP-1a 1/1 (E) and 2/2 (F) mice were removed and individually homoge-
nized, minced, and sonicated, after which the clarified cell lysates were assayed
via ELISA. Bars represent mean values for each group on the indicated day after
infection.
FIG. 2. Requirement of MIP-1a for the development of HSK. Ten MIP-1a
2/2 mice along with 10 age-matched 1/1 mice were infected topically with
2.5 3 105 PFU of HSV-1 strain RE and then monitored for the development of
corneal opacity. *, the treated group was significantly (P , 0.05) different from
the control group.
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three independent experiments. Histologically, the corneas
from MIP-1a 2/2 mice remained avascular and displayed only
scattered inflammatory cells (Fig. 3A), whereas the corneas of
1/1 hosts were characterized by copious inflammatory cells,
neovascularization, and corneal epithelial ulceration (Fig. 3B).
To further characterize the cellular infiltrate in the infected
corneas, CD41 T cells and neutrophils were enumerated by
immunohistochemical staining with appropriate antisera. Ta-
ble 1 shows that in contrast to the controls, no CD41 T cells
were detected in the eyes of MIP-1a 2/2 mice while the
neutrophil infiltrate was reduced by .80%. The presence of
some neutrophils in the pervascular region of the corneal lim-
bus of MIP-1a 2/2 mice suggested that a chemokine(s) in
addition to MIP-1a participated in promoting neutrophil mi-
gration into the HSV-1-infected tissue.
IL-2 and IFN-g expression in MIP-1a 1/1 and 2/2 mice.
HSK is characterized by elevated levels of the TH1 cytokines
IL-2 and IFN-g, and neutralization of either is reported to
suppress HSK development (13, 31). Both cytokines were
readily detected in the corneas of 1/1 hosts as expected on
day 14 (Fig. 4). However, the corneas of MIP-1a 2/2 mice
were virtually devoid of IL-2 and IFN-g, which is in agreement
with the dearth of T cells in this tissue. Assays for IFN-g at
earlier time points, i.e., days 4, 7, and 10 postinfection, re-
vealed that the mean levels in 2/2 mice were 9-, 3-, and
40-fold lower, respectively, than that seen in 1/1 mice. Tests
for IL-4, a TH2 cytokine, were negative at all time points in
both groups of animals. These results further indicate that
endogenous MIP-1a is associated with TH1 cytokine expres-
sion in the HSV-1-infected cornea.
MIP-2 and MCP-1 expression in MIP-1a 1/1 and 2/2
mice. In addition to MIP-1a, message for the chemokines
MIP-2 and MCP-1 is known to be induced in the BALB/c
cornea following HSV-1 infection (30). Figure 5 shows that
these two chemokines were also produced in 129 3 C57BL/6J
1/1 mice. MIP-2 was detected at low levels on day 3, increased
some fivefold by day 7, peaked at day 14, and persisted for at
least 3 weeks. In contrast, synthesis of MCP-1 was quite tran-
sient, being present in all hosts only on day 7. Interestingly, the
production of both chemokines was sharply reduced in the
MIP-1a 2/2 hosts. This reduction presumedly contributed to
the paucity of infiltrating leukocytes in the HSV-1-infected
cornea. It appears that MIP-1a synthesis can influence the
FIG. 3. Photomicrographs of cross sections of corneas from MIP-1a 2/2 (A) and MIP-1a 1/1 (B) mice removed 28 days after infection. Four corneas per group
were examined in two independent experiments. Magnification, 382.
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expression of both MCP-1 and MIP-2, probably by regulating
infiltration of the cells that produce them.
HSV-1 clearance in MIP-1a 2/2 mice is not impaired. It
was of interest to determine whether the loss of MIP-1a ren-
dered the mutant mice more susceptible to HSV-1 replication.
To investigate this question, infectious virus titers in the eyes of
mutant mice were compared with that found in the 1/1 con-
trols following topical infection of the cornea with 2.5 3 105
PFU. Figure 6 shows that there was no significant difference in
virus growth or clearance between the two groups. At a higher
challenge dose (7 3 105 PFU) some mortality (20 to 25%) was
seen, but it was comparable for both groups. Previous analysis
did not reveal any overt hematopoietic abnormalities in
MIP-1a 2/2 mice (5). We found that sera collected from 2/2
hosts 12 days postinfection had virus neutralizing titers (1:40 to
1:160) which were equivalent to that seen in 1/1 mice. Thus,
MIP-1a does not appear to influence the production of virus-
specific antibody.
DISCUSSION
In this study, mice with a disrupted gene for MIP-1a were
used to test the hypothesis that this CC chemokine was an
essential participant in the development of HSK. We found
that animals which did not make MIP-1a protein had markedly
reduced corneal opacity compared to the wild-type controls.
Histologically, corneas from the gene knockout mice displayed
a dramatic reduction in T-cell and neutrophil migration. In
addition, the levels of cytokines IL-2 and IFN-g as well as the
chemokines MIP-2 and MCP-1 were significantly lower than
those in 1/1 mice. The paucity of inflammatory cells and
proinflammatory mediators in the corneas of MIP-1a 2/2
mice provides a logical explanation for the attenuation of oc-
ular disease. Additional evidence supporting MIP-1a partici-
pation in HSK development comes from the findings that
HSV-1 infection of the corneas of 1/1 mice led to the pro-
duction of MIP-1a and that expression of the chemokine was
correlated temporally with the migration of leukocytes into
infected ocular tissue and the initiation of clinical corneal
disease. Also, higher levels of MIP-1a were found in those
corneas which displayed the most severe ocular opacity (data
not shown). Recent studies using BALB/c mice in our labora-
tory have shown that IL-10 treatment, which suppresses HSK
development (35), also suppresses MIP-1a synthesis. In addi-
tion, passive transfer of specific neutralizing antibody to
MIP-1a modestly but significantly reduced the severity of cor-
neal opacity in this mouse strain. Collectively, our results
strongly support the premise that MIP-1a plays a critical role
in HSK development in the mouse.
MIP-1a is not made constitutively by resident murine cor-
neal cells. In fact, message and protein for this chemokine
could not be detected in the cornea until some 5 to 7 days
postinfection (30) (Fig. 1). This finding suggests that infiltrat-
FIG. 4. Reduction of the inflammatory cytokines IFN-g and IL-2 in MIP-1a
2/2 mice. Groups of seven MIP-1a 2/2 mutant mice (F) along with seven
age-matched 1/1 mice (E) received 2.5 3 105 PFU of HSV-1 strain RE.
Fourteen days after infection, the corneas were excised and individually assayed
for IL-2, IFN-g, and IL-4 via ELISA.
FIG. 5. Reduction of the inflammatory chemokines MCP-1 and MIP-2 in
MIP-1a 2/2 mice. Groups of MIP-1a 2/2 mice (F) along with age-matched
1/1 mice (E) received 2.5 3 105 PFU of HSV-1 strain RE. On the days
indicated after infection, corneas were excised and individually assayed for
MCP-1 and MIP-2 via ELISA. Bars represent mean values for each group on the
indicated day after infection.
TABLE 1. CD4 T-cell and neutrophil numbers in corneas of MIP-
1a 1/1 and 2/2 mice




No. of cellsc (mean counts
6 SE) Pd
MIP-1a 1/1 MIP-1a 2/2
14 CD4 T cells 27 6 2 0 0.001
Neutrophils 112 6 9 19 6 2 0.006
21 CD4 T cells 24 6 2 0 0.001
Neutrophils 261 6 14 36 6 2 0.002
a The scarified right cornea was infected with 2.5 3 105 PFU of the RE strain
of HSV-1. Three corneas from each treatment group were obtained on the days
indicated, and individual frozen sections were prepared.
b CD4 T cells and neutrophils were identified by immunohistochemical stain-
ing of frozen sections by using monoclonal antibodies GK1.5 and RB6-8C5,
respectively.
c The designated cell populations were counted in six different 403 fields in
each of three sections from each cornea (total of 36 fields per time point).
d Determined by the two-tailed Student t test.
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ing leukocytes are the principal producers. In rodents, neutro-
phils (23), T cells (17), and macrophages (26, 39) all can make
MIP-1a and constitute potential cellular sources.
Our results are in agreement with previous work in which
the response of MIP-1a 2/2 mice to two other virus infections
was studied (5). It was observed that MIP-1a null mice were
resistant to coxsackievirus-induced myocarditis and had re-
duced lung inflammation following influenza virus infection. In
both virus infections, there was reduced mononuclear cell in-
filtration. We observed that CD4 T-cell migration into the
HSV-1-infected cornea was dramatically reduced in 2/2 mice.
This reduction in T-cell migration conforms with in vitro ob-
servation that MIP-1a is chemotactic for T cells (22, 32). In
addition, other investigators have observed that administration
of neutralizing antibodies to MIP-1a can result in diminished
influx of T cells at the site of inflammation (6, 15), although
this is not invariably the case (14, 26, 28).
CC chemokines are generally thought to be chemotactic for
lymphocytes and cells of the monocyte lineage (2, 21, 33). Our
data show that MIP-1a is also needed for maximal recruitment
of neutrophils into the cornea. Similarly, other investigators
have reported that administration of neutralizing antibody to
MIP-1a reduces neutrophil influx into the peritoneal cavity (1)
and lungs (14, 24) of different rodent models. Neutralizing
MIP-1a antibody treatment also suppressed neutrophil migra-
tion into cryptococcal antigen-injected gelatin sponges im-
planted subcutaneously (6). One explanation for suppressed
neutrophil infiltration is that MIP-1a is directly chemotactic
for these cells. This possibility exists since mouse neutrophils
have recently been reported to express CCRI, a receptor for
MIP-1a, and MIP-1a was shown to be chemotactic for mouse
neutrophils in vitro (8). Alternatively, or in addition, MIP-1a
may act indirectly by inducing cells to make molecules which
promote neutrophil chemotaxis. Our observation that MIP-1a
2/2 mice have decreased expression of MIP-2, a potent mu-
rine neutrophil chemoattractant (37, 40), suggests that MIP-1a
can influence the expression of CXC chemokines. Further
studies are needed to determine whether MIP-1a acts directly
or indirectly to reduce neutrophils and T cells and lower cyto-
kine and chemokine levels.
Cook et al. (5) observed that influenza virus was cleared
more slowly in MIP-1a 2/2 mice. On the other hand, coxsack-
ievirus-infected 2/2 animals were not found to have higher
virus titers than the 1/1 controls (4). Since T cells appear to
be needed for HSV-1 clearance from infected tissue (3, 18, 27,
34), and MIP-1a production in 1/1 mice was correlated with
the removal of virus, it was anticipated that virus growth would
be more exuberant in MIP-1a 2/2 mice. Surprisingly, there
was no difference in clearance of HSV-1 from the eyes (Fig. 6)
and trigeminal ganglia (unpublished observations) of 2/2
hosts compared to 1/1 mice. These results are analogous to
that seen in coxsackievirus infection wherein 2/2 animals
were not found to have higher virus titers than the 1/1 con-
trols (4). It thus appears that MIP-1a participation in virus
clearance is variable. The requirement for this chemokine may
depend on the nature of the infecting virus and/or the partic-
ular tissue that is infected.
The unfolding chemokine story has established that different
chemokines can have similar structures, bind to the same re-
ceptor, and have overlapping activity in chemotactic assays.
For example, MIP-1b is 60% homologous to MIP-1a at the
amino acid level, binds to some of the same receptors, and in
vitro is a chemoattractant for many of the same cell types as
MIP-1a (10, 11). Thus, it was initially considered likely that a
similar chemokine would functionally compensate for a miss-
ing chemokine. However, in order for one chemokine to fully
compensate for another in vivo, it needs to be produced in the
same time frame in the target tissue and be as potent. It must
also recruit the same leukocyte subsets and, after receptor
binding, function as an agonist (as opposed to an antagonist).
Given these multiple requirements, it perhaps is not surprising
that in an in vivo environment one chemokine may not easily
substitute for another.
In summary, we have shown that a single chemokine, MIP-
1a, has a dominant role in virus-induced ocular inflammation.
MIP-1a has also been implicated in inflammatory cell re-
sponses associated with human diseases such as sarcoidosis and
idiopathic pulmonary fibrosis (29). It may be possible to de-
velop antagonists of MIP-1a that will be clinically useful (9),
especially since our results show that interference with the
biological activity of MIP-1a does not necessarily compromise
the host’s capacity to clear infectious agents.
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